News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Optimizing Treatment Strategies in Relapsed/Refractory Metastatic CRC

EP. 1: Continuum of Care for Metastatic CRC

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

EP. 2: Initiating Therapy for mCRC

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

EP. 3: Second-Line Treatment for mCRC

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

EP. 4: Later Lines of Therapy for mCRC

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

EP. 5: CORRECT, RECOURSE, and ReDOS Trials in mCRC

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

EP. 6: Therapeutic Agents in Relapsed/Refractory mCRC

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

EP. 7: Sequencing in mCRC: Later-Line Therapies

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

EP. 8: Using I/O in MSI-H Tumors in mCRC

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

EP. 9: Role of I/O Combination Therapies in mCRC

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

EP. 10: Key Trials in mCRC: I/O Combination Therapies

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

EP. 11: Future Directions in Later Line Therapy for mCRC

ByFortunato Ciardiello, MD, PhD, University of Campania,Axel Grothey, MD, West Cancer Center & Research Institute,Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center

June 29th 2020

Trending on OncLive

FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC

HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts

Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC

SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma

Five Under 5: Top Oncology Videos for the Week of 1/25